Tommy G. Thompson's most recent trade in United Therapeutics Corp was a trade of 3,650 Stock Options done . Disclosure was reported to the exchange on July 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 3,650 | 3,650 | - | - | Stock Options | |
| Healthpeak Properties Inc. | Tommy G. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 17.27 per share. | 28 May 2025 | 5,777 | 144,290 (0%) | 0% | 17.3 | 99,769 | Common Stock |
| Healthpeak Properties Inc. | Tommy G. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 17.36 per share. | 09 May 2025 | 5,700 | 138,513 (0%) | 0% | 17.4 | 98,974 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 2,500 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 09 May 2025 | 2,500 | 10,980 (0%) | 0% | 175.4 | 438,575 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale of securities on an exchange or to another person at price $ 305.15 per share. | 09 May 2025 | 2,500 | 8,480 (0%) | 0% | 305.1 | 762,865 | Common Stock |
| Healthpeak Properties Inc. | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 10,657 | 132,813 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 14 Apr 2025 | 325 | 14,779 (0%) | 0% | 1.0 | 326 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale of securities on an exchange or to another person at price $ 318.80 per share. | 24 Mar 2025 | 2,500 | 8,480 (0%) | 0% | 318.8 | 796,991 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 24 Mar 2025 | 2,500 | 10,980 (0%) | 0% | 175.4 | 438,575 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 2,500 | 2,500 | - | - | Stock Option | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,500 | 5,000 | - | - | Stock Option | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale of securities on an exchange or to another person at price $ 318.34 per share. | 28 Feb 2025 | 2,500 | 8,480 (0%) | 0% | 318.3 | 795,838 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 28 Feb 2025 | 2,500 | 10,980 (0%) | 0% | 175.4 | 438,575 | Common Stock |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 14,454 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,890 | 2,890 | - | - | Stock Options | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 26 Jun 2024 | 7,500 | 15,980 (0%) | 0% | 175.4 | 1,315,725 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2024 | 7,500 | 7,500 | - | - | Stock Options | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale of securities on an exchange or to another person at price $ 318.81 per share. | 26 Jun 2024 | 5,085 | 10,895 (0%) | 0% | 318.8 | 1,621,160 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale of securities on an exchange or to another person at price $ 320.21 per share. | 26 Jun 2024 | 1,515 | 9,380 (0%) | 0% | 320.2 | 485,121 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale of securities on an exchange or to another person at price $ 320.84 per share. | 26 Jun 2024 | 900 | 8,480 (0%) | 0% | 320.8 | 288,754 | Common Stock |
| Healthpeak Properties Inc. | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 9,575 | 122,156 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 249.51 per share. | 11 Mar 2024 | 5,000 | 8,480 (0%) | 0% | 249.5 | 1,247,550 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 11 Mar 2024 | 5,000 | 13,480 (0%) | 0% | 88.0 | 440,150 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 5,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 2,000 | 5,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 08 Mar 2024 | 2,000 | 10,480 (0%) | 0% | 88.0 | 176,060 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 243.05 per share. | 08 Mar 2024 | 2,000 | 8,480 (0%) | 0% | 243.1 | 486,100 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 06 Mar 2024 | 2,000 | 10,480 (0%) | 0% | 88.0 | 176,060 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2024 | 2,000 | 7,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 236.97 per share. | 06 Mar 2024 | 2,000 | 8,480 (0%) | 0% | 237.0 | 473,940 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,000 | 9,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 231.92 per share. | 01 Mar 2024 | 2,000 | 8,480 (0%) | 0% | 231.9 | 463,840 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 01 Mar 2024 | 2,000 | 10,480 (0%) | 0% | 88.0 | 176,060 | Common Stock |
| United Therapeutics Corp | Thompson Tommy G. | Director | Sale or transfer of securities back to the company at price $ 227.03 per share. | 23 Feb 2024 | 2,000 | 8,480 (0%) | 0% | 227.0 | 454,060 | Common Stock |
| United Therapeutics Corp | Tommy Thompson G. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 23 Feb 2024 | 2,000 | 10,480 (0%) | 0% | 88.0 | 176,060 | Common Stock |
| United Therapeutics Corp | Tommy Thompson G. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 2,000 | 11,000 | - | - | Share Tracking Award | |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 8,500 | 8,500 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 4,560 | 4,560 | - | - | Stock Options | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 8,480 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 1,000 | 14,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 217.22 per share. | 02 Jun 2023 | 1,000 | 7,600 (0%) | 0% | 217.2 | 217,220 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 02 Jun 2023 | 1,000 | 8,600 (0%) | 0% | 88.0 | 88,030 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2023 | 2,500 | 2,500 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2023 | 2,500 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 24 Mar 2023 | 2,500 | 10,100 (0%) | 0% | 63.9 | 159,750 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 219.11 per share. | 24 Mar 2023 | 2,500 | 7,600 (0%) | 0% | 219.1 | 547,775 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 24 Mar 2023 | 2,500 | 10,100 (0%) | 0% | 63.9 | 159,750 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 223.96 per share. | 24 Mar 2023 | 2,500 | 7,600 (0%) | 0% | 224.0 | 559,900 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 03 Mar 2023 | 2,500 | 10,100 (0%) | 0% | 63.9 | 159,750 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 248.69 per share. | 03 Mar 2023 | 2,500 | 7,600 (0%) | 0% | 248.7 | 621,725 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 2,500 | 5,000 | - | - | Share Tracking Award | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,205 | 10,205 | - | - | 2023 Restricted Share Unit Grant | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 4,582 | 152,248 (0%) | 0% | - | Common shares, $0.01 par value | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 4,582 | 4,582 | - | - | 2022 Restricted Share Unit Grant | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 4,358 | 147,666 (0%) | 0% | - | Common shares, $0.01 par value | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 4,358 | 0 | - | - | 2021 Restricted Share Unit Grant | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 2,500 | 7,500 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 246.04 per share. | 28 Feb 2023 | 2,500 | 7,600 (0%) | 0% | 246.0 | 615,100 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 28 Feb 2023 | 2,500 | 10,100 (0%) | 0% | 63.9 | 159,750 | Common Stock |
| Scilex Holding Company | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 15.16 per share. | 13 Dec 2022 | 17,760 | 19,060 (0%) | 0% | 15.2 | 269,242 | Common shares, $0.01 par value |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Purchase of securities on an exchange or from another person at price $ 15.04 per share. | 13 Dec 2022 | 6,575 | 25,635 (0%) | 0% | 15.0 | 98,888 | Common shares, $0.01 par value |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 23 Nov 2022 | 5,000 | 12,600 (0%) | 0% | 63.9 | 319,500 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 5,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 266.86 per share. | 23 Nov 2022 | 5,000 | 7,600 (0%) | 0% | 266.9 | 1,334,300 | Common Stock |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 34,175 | 34,175 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 2,976 | 5,954 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 2,976 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 2,490 | 4,980 | - | - | Stock Options | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 1,080 | 7,600 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 1,080 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 880 | 880 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 224.78 per share. | 26 May 2022 | 2,200 | 6,520 (0%) | 0% | 224.8 | 494,516 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 26 May 2022 | 2,200 | 8,720 (0%) | 0% | 48.1 | 105,842 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 2,200 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2022 | 1,500 | 2,200 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 178.46 per share. | 29 Mar 2022 | 1,500 | 6,520 (0%) | 0% | 178.5 | 267,690 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 29 Mar 2022 | 1,500 | 8,020 (0%) | 0% | 48.1 | 72,165 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 1,509 | 3,700 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 16 Mar 2022 | 1,509 | 8,029 (0%) | 0% | 48.1 | 72,598 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 184.49 per share. | 16 Mar 2022 | 1,509 | 6,520 (0%) | 0% | 184.5 | 278,395 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 182.55 per share. | 16 Mar 2022 | 1,500 | 6,520 (0%) | 0% | 182.6 | 273,825 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 16 Mar 2022 | 1,500 | 8,020 (0%) | 0% | 48.1 | 72,165 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 1,500 | 5,209 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 178.82 per share. | 15 Mar 2022 | 1,500 | 6,520 (0%) | 0% | 178.8 | 268,230 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,500 | 6,709 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 15 Mar 2022 | 1,500 | 8,020 (0%) | 0% | 48.1 | 72,165 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 1,000 | 8,209 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 167.78 per share. | 10 Mar 2022 | 1,000 | 6,520 (0%) | 0% | 167.8 | 167,780 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 10 Mar 2022 | 1,000 | 7,520 (0%) | 0% | 48.1 | 48,110 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 03 Mar 2022 | 1,500 | 8,020 (0%) | 0% | 48.1 | 72,165 | Common Stock |
| United Therapeutics Corp | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2022 | 1,500 | 9,209 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Tommy G. Thompson | Director | Sale or transfer of securities back to the company at price $ 174.96 per share. | 03 Mar 2022 | 1,500 | 6,520 (0%) | 0% | 175.0 | 262,440 | Common Stock |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 9,164 | 9,164 | - | - | 2022 Restricted Share Unit Grant | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 4,358 | 4,358 | - | - | 2021 Restricted Share Unit Grant | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 4,358 | 134,546 (0%) | 0% | - | Common shares, $0.01 par value | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 3,886 | 0 | - | - | 2020 Restricted Share Unit Grant | |
| Healthpeak Properties - REIT | Tommy G. Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 3,886 | 138,432 (0%) | 0% | - | Common shares, $0.01 par value |